The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Special Section

Early Career Psychiatrists

The objective of the Early Career Psychiatrists section is to encourage the academic development of early career psychiatrists. Manuscripts selected for this section will be those deemed through the review process to represent excellent work from the next generation of researchers in psychiatry.

Eligibility criteria for first authors:

  • Trained psychiatrists with an MD, MD/PhD, or DO degree
  • Less than 5 years from completion of training
  • Current academic rank no higher than Assistant Professor

Page 2

JCP
Subcallosal Cingulate Gyrus Deep Brain Stimulation for TRD
Original Research

June 28, 2023

DBS targeting the subcallosal cingulate gyrus to treat depressive symptoms resulted in response and remission rates of 75% and 62.5%.
Carlo Alemany, Dolors Puigdemont, Ana Martín-Blanco, et al
JCP
Mild Vitamin C Deficiency Is Common in Psychiatric Inpatients
Original Research

June 14, 2023

Almost two-thirds of inpatients met criteria for mild vitamin C deficiency, and folate and vitamin D levels strongly predicted vitamin C levels.
Bilal A. Bari, Ana Ivkovic, Bryce A. Wininger
JCP
Weight Loss and Lifestyle Intervention for Obstructive Sleep Apnea
Original Research

June 12, 2023

A weight loss and lifestyle intervention improved OSA-related impaired daily functioning and psychiatric symptoms.
Almudena Carneiro-Barrera, Francisco J. Amaro-Gahete, Germán Sáez-Roca, et al
JCP
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
Systematic Review

May 10, 2023

Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.
Sandeep M. Nayak, Melissa K. Bradley, Bethea A. Kleykamp, et al
JCP
Ketamine vs Esketamine for TRD
Original Research

February 1, 2023

Are ketamine and esketamine equally efficacious? This observational study compares the efficacy of subanesthetic intravenous ketamine with that of intranasal esketamine for treatment-resistant depression in a real-world clinical setting.
Balwinder Singh, Simon Kung, Vanessa Pazdernik, et al
JCP
Comparison of Catatonia Risk of 30 Antipsychotics
Original Research

December 14, 2022

In this postmarketing study, first-generation antipsychotics were associated with a greater risk of catatonia syndromes compared to second-generation antipsychotics.
Julien Da Costa, Etienne Very, Vanessa Rousseau, et al
JCP
Rapidity of Improvement With Intranasal Esketamine for MDD
Meta-Analysis

December 12, 2022

This meta-analysis found that augmenting antidepressants with intranasal esketamine vs placebo was more effective in reducing depression severity at 24 hours and study endpoint.
Rebecca S. Hock, Anna Feeney, Nadia Iovieno, et al
JCP
Factors Associated With Posttraumatic Stress After COVID-19 Hospitalization
Original Research

December 7, 2022

Patients hospitalized with COVID-19 showed persistent posttraumatic stress symptoms 6 months later. These symptoms were linked to dissociative experiences while hospitalized and longer distances between home and the hospital.
Victor Pitron, Willys Cantenys, Anne Herbelin, et al
JCP
Effect of Benzodiazepines on Antidepressant Effects of Ketamine
Original Research

November 14, 2022

Findings of studies examining the impact of benzodiazepines on antidepressant effects of ketamine are contradictory. This study assessed whether concomitant oral benzodiazepines differentially affected treatment response to ketamine versus…
Anna Feeney, Bettina B. Hoeppner, Marlene P. Freeman, et al
JCP
Combined Ketamine and Monoamine Oxidase Inhibitors
Systematic Review

October 24, 2022

Little is known about actual side effects of augmentation of ketamine to monoamine oxidase inhibitors (MAOIs). This systematic review and cases series evaluated symptoms of serotonin syndrome and hypertension…
Jolien K. E. Veraart, Sanne Y. Smith-Apeldoorn, Mats Kutscher, et al
JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
Charles Ouazana-Vedrines, Thomas Lesuffleur, Pierre Denis, et al
JCP
Fear Learning, Extinction Learning, and Reversal Learning in OCD
Systematic Review

October 5, 2022

Alterations in fear learning, extinction learning, and reversal learning are key processes in OCD. This review summarizes the research and its applications for optimizing OCD treatment.
Elizabeth R. Steuber, Joseph F. McGuire

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe